{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:58:40Z","timestamp":1793109520394,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5R01AI118814"],"award-info":[{"award-number":["5R01AI118814"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.antiviral.2019.04.004","type":"journal-article","created":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T09:28:01Z","timestamp":1554629281000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Efficacy of a ML336 derivative against Venezuelan and eastern equine encephalitis viruses"],"prefix":"10.1016","volume":"167","author":[{"given":"Colleen B.","family":"Jonsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon D.","family":"Gabbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Kyu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Julander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hoon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Stabenow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.04.004_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2016.11.018","article-title":"Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay","volume":"138","author":"Adcock","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.04.004_bib2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2217\/fvl.11.50","article-title":"Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella","volume":"6","author":"Aguilar","year":"2011","journal-title":"Future Virol."},{"key":"10.1016\/j.antiviral.2019.04.004_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CMR.7.1.89","article-title":"Medically important arboviruses of the United States and Canada","volume":"7","author":"Calisher","year":"1994","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2019.04.004_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coviro.2017.11.006","article-title":"Innate immune control of alphavirus infection","volume":"28","author":"Carpentier","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2019.04.004_bib5","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJMoa1212628","article-title":"Eastern equine encephalitis in Latin America","volume":"369","author":"Carrera","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.04.004_bib6","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1093\/jac\/dkx224","article-title":"A compendium of small molecule direct-acting and host-targeting inhibitors as therapies against alphaviruses","volume":"72","author":"Ching","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2019.04.004_bib7","series-title":"ML336: Development of Quinazolinone-Based Inhibitors against Venezuelan Equine Encephalitis Virus (VEEV), Probe Reports from the NIH Molecular Libraries Program","author":"Chung","year":"2010"},{"key":"10.1016\/j.antiviral.2019.04.004_bib8","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1128\/AAC.00282-16","article-title":"Discovery of a broad-spectrum antiviral compound that inhibits pyrimidine biosynthesis and establishes a type 1 interferon-independent antiviral state","volume":"60","author":"Chung","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.04.004_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004213","article-title":"Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2","volume":"10","author":"Chung","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.04.004_bib10","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1128\/JVI.76.17.8641-8649.2002","article-title":"Modification of Asn374 of nsP1 suppresses a Sindbis virus nsP4 minus-strand polymerase mutant","volume":"76","author":"Fata","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.04.004_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004185","article-title":"Influenza virus drug resistance: a time-sampled population genetics perspective","volume":"10","author":"Foll","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.antiviral.2019.04.004_bib12","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1128\/JVI.07223-11","article-title":"Early events in alphavirus replication determine the outcome of infection","volume":"86","author":"Frolov","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.04.004_bib13","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1128\/jvi.63.3.1194-1202.1989","article-title":"Mapping of RNA- temperature-sensitive mutants of Sindbis virus: complementation group F mutants have lesions in nsP4","volume":"63","author":"Hahn","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.04.004_bib14","series-title":"Fields Virology","author":"Knipe","year":"2013"},{"key":"10.1016\/j.antiviral.2019.04.004_bib15","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.4269\/ajtmh.17-0927","article-title":"Eastern equine encephalitis virus in the United States, 2003-2016","volume":"98","author":"Lindsey","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2019.04.004_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.44.4.859-866.2000","article-title":"Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon","volume":"44","author":"Markland","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.04.004_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2019.04.004_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/JVI.01067-13","article-title":"Evolution of the influenza A virus genome during development of oseltamivir resistance in vitro","volume":"88","author":"Renzette","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.04.004_bib19","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1086\/513978","article-title":"Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995","volume":"175","author":"Rivas","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.04.004_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.virol.2008.10.030","article-title":"Characterization of purified Sindbis virus nsP4 RNA-dependent RNA polymerase activity in vitro","volume":"384","author":"Rubach","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.04.004_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.2008.00670.x","article-title":"Host responses to alphavirus infection","volume":"225","author":"Ryman","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2019.04.004_bib22","first-page":"3","article-title":"Localized eastern equine encephalitis in Santiago del Estero Province, Argentina, without human infection","volume":"51","author":"Sabattini","year":"1991","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.antiviral.2019.04.004_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0042-6822(90)90052-S","article-title":"Temperature sensitive shut-off of alphavirus minus strand RNA synthesis maps to a nonstructural protein, nsP4","volume":"174","author":"Sawicki","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.04.004_bib24","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1021\/jm501203v","article-title":"Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus","volume":"57","author":"Schroeder","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2019.04.004_bib25","article-title":"beta-D-N(4)-hydroxycytidine is a potent anti-alphavirus compound that induces high level of mutations in viral genome","volume":"92","author":"Urakova","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.04.004_bib26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2012.04.002","article-title":"Alphaviruses: population genetics and determinants of emergence","volume":"94","author":"Weaver","year":"2012","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219300191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219300191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:28:05Z","timestamp":1759062485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219300191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":26,"alternative-id":["S0166354219300191"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.04.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a ML336 derivative against Venezuelan and eastern equine encephalitis viruses","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}